In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Perfume harassment

This article was originally published in The Rose Sheet

Executive Summary

U.S. District Court for the District of Columbia dismisses pro se complaint filed by man seeking $200 mil. from FDA for agency's incompetence in approving "a steroid perfume that constitutes sexual harassment by those who wear [it]." Smelling the perfume evokes "dirty thoughts," plaintiff claims. Plaintiff himself was a victim of the substance - which "poses as great a threat to society in general as the atom bomb" - losing his job due to perfume's effect over him, according to Oct. 2 statement. In cases where a plaintiff is proceeding in forma pauperis - without the funds to cover the normal costs of a lawsuit - court is obligated to dismiss if complaint fails to state a claim upon which relief may be granted, as in complaint described



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts